0001127602-21-023391.txt : 20210809 0001127602-21-023391.hdr.sgml : 20210809 20210809191433 ACCESSION NUMBER: 0001127602-21-023391 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURZIK CATHERINE M CENTRAL INDEX KEY: 0001261141 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 211157925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0402 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-08-06 0000313143 HAEMONETICS CORP HAE 0001261141 BURZIK CATHERINE M 125 SUMMER STREET BOSTON MA 02110 1 Common Stock 2021-08-06 4 A 0 3077 A 16815 D The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. /s/ Thomas V. Powers, attorney-in-fact for Ms. Burzik 2021-08-09